You are here
Search FHI 360
Search FHI 360
Apply Health filter
Remove Research services filter
Quality assurance (1)
Apply Quality assurance filter
Training and technical assistance (2)
Apply Training and technical assistance filter
Remove Article filter
Remove HIV and AIDS filter
HIV and AIDS
Remove Key populations filter
U.S. HIV programs (7)
Apply U.S. HIV programs filter
Remove HIV prevention filter
Clinical laboratory quality assurance (1)
Apply Clinical laboratory quality assurance filter
Clinical trials design and implementation (1)
Apply Clinical trials design and implementation filter
Family planning (2)
Apply Family planning filter
Health: Technology (1)
Apply Health: Technology filter
Infectious and tropical diseases (1)
Apply Infectious and tropical diseases filter
Maternal, newborn and child health (1)
Apply Maternal, newborn and child health filter
Reproductive and sexual health (2)
Apply Reproductive and sexual health filter
Reproductive health research (1)
Apply Reproductive health research filter
Social and behavior change (1)
Apply Social and behavior change filter
Apply Tanzania filter
Apply Thailand filter
Apply Zambia filter
Apply Zimbabwe filter
Apply Announcement filter
Apply Feature filter
Apply News filter
Start a New Search
Search within these results
HIV and AIDS
9 Results Found
Expanding access to male circumcision in Zambia: The ZPCT II experience
This piece originally appeared on FHI 360's Degrees Blog. You can read the original text here. By Michael Welsh, PhD, MA, FHI 360 Country Director in Zambia, and Patrick Katayamoyo, MD, MPH, Associate Technical Director, ZPCT II
Toward elimination of mother-to-child HIV transmission in Zambia: Early infant diagnosis specimen referral system
This piece originally appeared on FHI 360's Degrees Blog. For the complete text, please visit: http://degrees.fhi360.org/toward-elimination-of-mother-to-child-hiv-transmission-in-zambia-early-infant-diagnosis-specimen-referral-system/. By Michael...
Final results of FEM-PrEP HIV-prevention study indicate great attention to adherence will be required in PrEP programs
RESEARCH TRIANGLE PARK, NC — Results of the FHI 360 FEM-PrEP HIV-prevention trial reinforce the key role of adherence in HIV-prevention studies and the need to determine better approaches to support adherence in future pre-exposure prophylaxis (PrEP...
'Science' names HIV prevention trial as breakthrough of the year
RESEARCH TRIANGLE PARK, NC — Today, Science named the HIV Prevention Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this important achievement. This is the second year in a...
VOICE HIV prevention trial discontinues Tenofovir gel arm
RESEARCH TRIANGLE PARK, NC — The Microbicides Trials Network (MTN) announced today that it will discontinue testing tenofovir vaginal gel in the HIV prevention trial VOICE (Vaginal and Oral Interventions to Control the Epidemic). This decision came...
HPTN 043 Project Accept study published in the Lancet Infectious Diseases demonstrates that community mobilization boosts HIV testing rates in developing countries
The addition of community mobilization activities and support services to a mobile HIV counseling and testing program can greatly improve the rates of initial and repeat testing in remote rural communities, according to new research supported by the...
FHI selected as preferred provider to a consortium of product development partnerships
RESEARCH TRIANGLE PARK, NC — FHI has been selected as one of six preferred providers offering their clinical research expertise to a consortium of 14 global health Product Development Partnerships (PDPs). The consortium of PDPs is working to develop...
FHI congratulates iPrEx team on study showing reduced risk of HIV infection in men
FHI welcomes the exciting proof of concept study results for oral Truvada pre-exposure prophylaxis (PrEP) therapy, published online today in the New England Journal of Medicine. The iPrEx study found that the daily use of an antiretroviral (ARV)...
FHI 360 statement on the Heffron et al study and hormonal contraceptives and HIV risk
On October 4, 2011 The Lancet Infectious Diseases published an article by Renee Heffron and a group of researchers at the University of Washington. The study was conducted among nearly 3,800 HIV-serodiscordant couples (in which one partner is HIV...